The Clinical core serves the USC Alzheimer's Disease Research Center and supports regional and national Alzheimer research by developing and maintaining longitudinal cohorts of diverse backgrounds that contribute to research into the prevention and treatment of late-life cognitive impairment and neurodegeneration. The primary role of the ADRC Clinical core is to provide systematic data to the National Alzheimer Coordinating Center (NACC), local and national research studies, and well-characterized, longitudinally- followed participants who range from cognitively non-impaired to dementia. The core is organized to support the USC ADRC's focus on Latinos, its scientific themes vascular factors in Alzheimer disease, and translational research. Hence, the target samples for the core include cognitively non-impaired and impaired with and without vascular risk factors, Latinos, participants who will donate their brains for autopsy, i.e., the brain research study, and participants for clinical translational studies and clinical trials. The Clinical core works with the other ADRC cores to meet its goals to: (1) advance clinical research on Alzheimer-related disorders by supporting ADRC-affiliated research projects including the vascular risk factors and neurodegeneration projects; (2) recruiting, assessing, and following participants in the brain research (autopsy) study in collaboration with the Neuropathology core to enhance the scientific value of autopsies, share data and bio-specimens with researchers, and perform clinicopathological correlation to improve diagnoses; (3) contribute to and advance innovation and the development of methods to better detect, diagnose and intervene in cognitive impairment; and (4) recruit our diverse community's participation in research, lower barriers to access, inform and educate by training students, physicians, and research associates by working with the Outreach, Recruitment, and Education core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005142-34
Application #
9462862
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
34
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Aydogan, Dogu Baran; Jacobs, Russell; Dulawa, Stephanie et al. (2018) When tractography meets tracer injections: a systematic study of trends and variation sources of diffusion-based connectivity. Brain Struct Funct 223:2841-2858
Gahm, Jin Kyu; Shi, Yonggang; Alzheimer’s Disease Neuroimaging Initiative (2018) Riemannian metric optimization on surfaces (RMOS) for intrinsic brain mapping in the Laplace-Beltrami embedding space. Med Image Anal 46:189-201
Emrani, Sheina; Libon, David J; Lamar, Melissa et al. (2018) Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall. J Alzheimers Dis 61:917-928
Hernandez, Gerson; Zhao, Liqin; Franke, Adrian A et al. (2018) Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor ?-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. Menopause 25:191-196
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Ho, Jean K; Nation, Daniel A; Alzheimer’s Disease Neuroimaging Initiative (2018) Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease. J Int Neuropsychol Soc 24:693-702
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679

Showing the most recent 10 out of 590 publications